MALVERN, PA — TELA Bio Inc. (Nasdaq: TELA) will release its third-quarter 2026 financial results on November 10, giving investors an update on the medical technology company’s performance and operations in the soft-tissue reconstruction market.
The Malvern-based company scheduled a conference call and webcast for 4:30 p.m. Eastern Time that day, when management will discuss the quarterly results and provide a corporate update.
TELA Bio develops and markets surgical products designed to support soft-tissue reconstruction while reducing long-term reliance on permanent synthetic materials.
The company’s approach emphasizes preservation of patients’ existing anatomy and the use of their natural healing response during reconstructive procedures.
Investors seeking to participate in the November 10 conference call must register at least 15 minutes before the scheduled start, although the company recommends registering one day in advance.
Conference call registration is available at https://register-conf.media-server.com/register/BI49a49f61aace4175be1506712605ea62.
A live webcast and subsequent replay will be accessible through the Events & Presentations section of TELA Bio’s investor relations website.
Additional company information is available at www.telabio.com.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.